SENSEX NIFTY
You are here : Moneycontrol > Mutual Funds > Sector - Pharma & Healthcare > SBI Mutual Fund > SBI Pharma Fund (G)

SBI Pharma Fund (G)

PLAN: Regular OPTIONS: Growth
148.437 0.75 (0.51%)

NAV as on 27 Sep, 2016

CRISIL MF RANK

Not Ranked

Riskometer

HIGH

HIGH

  • Principal at high risk.
FUND FAMILY : SBI Mutual Fund FUND CLASS : Sector - Pharma & Healthcare
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
Holdings (Aug 31, 16)
Equity Sector Value
(Rs cr)
Assets %
Sun Pharma Pharmaceuticals 201.67 18.79
Divis Labs Pharmaceuticals 105.80 9.85
Aurobindo Pharm Pharmaceuticals 102.81 9.57
Strides Shasun Pharmaceuticals 76.10 7.09
Lupin Pharmaceuticals 53.36 4.97
Natco Pharma Pharmaceuticals 48.22 4.49
Alkem Lab Pharmaceuticals 46.43 4.32
Cipla Pharmaceuticals 45.84 4.27
Torrent Pharma Pharmaceuticals 44.06 4.10
Dr Lal PathLab Pharmaceuticals 38.94 3.63
Sector Allocation (Aug 31, 16)
  Sector   % 1-Year
High Low

Pharmaceuticals

87.38 95.88 91.18

Services

6.34 6.06 2.80
Asset Allocation (%) (Aug 31, 16)
Class
%

Equity

93.72

Others / Unlisted

0.02

Debt

0.00

Mutual Funds

N.A

Money Market

0.00

Cash / Call

6.26

Net Receivable / Payable

N.A
Concentration
Holdings
%

Top 5

50.27

Top 10

71.08
Sectors
%

Top 3

93.72
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.